Literature DB >> 20500091

Influence of particle size and material properties on mucociliary clearance from the airways.

Andreas Henning1, Marc Schneider, Noha Nafee, Leon Muijs, Erik Rytting, Xiaoying Wang, Thomas Kissel, Dirk Grafahrend, Doris Klee, Claus-Michael Lehr.   

Abstract

Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly noxious material from the airways, considerably limits the benefit of inhalation therapy. Although the principles of MC seem to be understood, there are still many open questions on mucociliary particle clearance. In this study a trachea-based in vitro model was used to investigate the effect of particle size, zeta-potential, and mucoadhesive particle properties on mucociliary particle clearance. As different sized particles (50-6000 nm) were tested at equal mass concentrations, size related factors, namely particle number and particle surface area, varied by several orders of magnitude between the experiments. Surprisingly, particle clearance for 50 nm up to 6000 nm-sized polystyrene particles did not differ significantly (p < 0.05): 50 nm (2.9 +/- 0.6 mm/min); 100 nm (3.8 +/- 0.9 mm/min); 1000 nm (3.8 +/- 0.8 mm/min); 6000 nm (3.2 +/- 0.6 mm/min). In clear contrast, particles prepared from different PLGA-based copolymers (polylactic-co-glycolic acid) showed a significant effect on particle transport. PEG-PLGA particles (polyethylene glycol) showed the fastest and normal transport rates (5.9 +/- 1.7 mm/min) compared to the ICRP's (International Commission of Radiological Protection) standard value for average tracheal transport rates (5.5 mm/min). Mucoadhesive chitosan-PLGA particles were transported at the slowest rate (0.7 +/- 0.3 mm/min) of all particles tested. Overall, particle size and zeta-potential seem to be relatively uncritical, whereas material properties and the related particle surface chemistry significantly influence mucociliary particle clearance. Considering these findings in future drug formulation seems to be a promising strategy to improve inhalation therapy by prolonged particle/drug residence time within the airways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20500091     DOI: 10.1089/jamp.2009.0806

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  19 in total

1.  Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.

Authors:  Alex Rygg; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2015-12-21       Impact factor: 4.200

2.  Particulate matter in cigarette smoke increases ciliary axoneme beating through mechanical stimulation.

Authors:  Chelsea R Navarrette; Joseph H Sisson; Elizabeth Nance; Diane Allen-Gipson; Justin Hanes; Todd A Wyatt
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-01-26       Impact factor: 2.849

3.  Particulate matter neurotoxicity in culture is size-dependent.

Authors:  Patricia Gillespie; Julianne Tajuba; Morton Lippmann; Lung-Chi Chen; Bellina Veronesi
Journal:  Neurotoxicology       Date:  2011-10-25       Impact factor: 4.294

4.  Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.

Authors:  Dalia Fakih; Ana M Rodriguez-Piñeiro; Sergio Trillo-Muyo; Christopher M Evans; Anna Ermund; Gunnar C Hansson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-29       Impact factor: 5.464

Review 5.  Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.

Authors:  Young H Lim; Kristin M Tiemann; David A Hunstad; Mahmoud Elsabahy; Karen L Wooley
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-25

Review 6.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

7.  Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Authors:  Nathalie Wauthoz; Philippe Deleuze; Amandine Saumet; Christophe Duret; Robert Kiss; Karim Amighi
Journal:  Pharm Res       Date:  2010-11-30       Impact factor: 4.200

8.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  Nano Today       Date:  2014-04-01       Impact factor: 20.722

9.  Comparison of CT-derived ventilation maps with deposition patterns of inhaled microspheres in rats.

Authors:  Richard E Jacob; Wayne J Lamm; Daniel R Einstein; Melissa A Krueger; Robb W Glenny; Richard A Corley
Journal:  Exp Lung Res       Date:  2014-12-16       Impact factor: 2.459

10.  Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs.

Authors:  Mark J Hoegger; Maged Awadalla; Eman Namati; Omar A Itani; Anthony J Fischer; Alexander J Tucker; Ryan J Adam; Geoffrey McLennan; Eric A Hoffman; David A Stoltz; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.